Hong Total Assets from 2010 to 2026

HKPD Stock   0.83  0.02  2.47%   
Hong Kong's Total Assets are increasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 7.9 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
10.8 M
Current Value
7.9 M
Quarterly Volatility
2.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Hong Kong financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hong Kong's main balance sheet or income statement drivers, such as Tax Provision of 103.4 K, Interest Income of 2.1 K or Depreciation And Amortization of 995 K, as well as many indicators such as Price To Sales Ratio of 0.52, Dividend Yield of 0.0 or PTB Ratio of 2.13. Hong financial statements analysis is a perfect complement when working with Hong Kong Valuation or Volatility modules.
  
Build AI portfolio with Hong Stock
Check out the analysis of Hong Kong Correlation against competitors.
Analyzing Hong Kong's Total Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Assets has evolved provides context for assessing Hong Kong's current valuation and future prospects.

Latest Hong Kong's Total Assets Growth Pattern

Below is the plot of the Total Assets of Hong Kong Pharma over the last few years. Total assets refers to the total amount of Hong Kong assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hong Kong Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Hong Kong's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hong Kong's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 9.42 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Hong Total Assets Regression Statistics

Arithmetic Mean4,769,547
Geometric Mean4,296,756
Coefficient Of Variation54.31
Mean Deviation2,084,272
Median3,406,754
Standard Deviation2,590,127
Sample Variance6.7T
Range7.4M
R-Value0.72
Mean Square Error3.5T
R-Squared0.51
Significance0
Slope367,927
Total Sum of Squares107.3T

Hong Total Assets History

20267.9 M
202510.8 M
20249.4 M
20238.7 M

Other Fundumenentals of Hong Kong Pharma

Hong Kong Total Assets component correlations

1.0-0.981.01.00.81.00.991.01.00.981.00.991.01.00.910.99
1.0-0.981.01.00.81.00.990.991.00.981.00.991.01.00.910.99
-0.98-0.98-0.98-0.97-0.86-0.99-0.99-0.98-0.99-0.99-0.98-0.99-0.98-0.98-0.96-0.99
1.01.0-0.981.00.781.00.990.991.00.971.00.991.01.00.90.99
1.01.0-0.971.00.740.990.980.990.990.961.00.980.991.00.880.98
0.80.8-0.860.780.740.830.850.790.810.890.80.850.810.780.880.85
1.01.0-0.991.00.990.831.00.991.00.991.00.991.00.990.910.99
0.990.99-0.990.990.980.851.00.991.00.991.01.01.00.990.931.0
1.00.99-0.980.990.990.790.990.990.990.971.00.990.991.00.910.99
1.01.0-0.991.00.990.811.01.00.990.981.00.991.01.00.910.99
0.980.98-0.990.970.960.890.990.990.970.980.980.990.980.970.930.99
1.01.0-0.981.01.00.81.01.01.01.00.980.991.01.00.910.99
0.990.99-0.990.990.980.850.991.00.990.990.990.990.990.990.931.0
1.01.0-0.981.00.990.811.01.00.991.00.981.00.991.00.910.99
1.01.0-0.981.01.00.780.990.991.01.00.971.00.991.00.90.99
0.910.91-0.960.90.880.880.910.930.910.910.930.910.930.910.90.93
0.990.99-0.990.990.980.850.991.00.990.990.990.991.00.990.990.93
Click cells to compare fundamentals

About Hong Kong Financial Statements

Hong Kong stakeholders use historical fundamental indicators, such as Hong Kong's Total Assets, to determine how well the company is positioned to perform in the future. Although Hong Kong investors may analyze each financial statement separately, they are all interrelated. For example, changes in Hong Kong's assets and liabilities are reflected in the revenues and expenses on Hong Kong's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Hong Kong Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets10.8 M7.9 M
Intangibles To Total Assets 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Hong Kong Pharma is a strong investment it is important to analyze Hong Kong's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Hong Kong's future performance. For an informed investment choice regarding Hong Stock, refer to the following important reports:
Check out the analysis of Hong Kong Correlation against competitors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Will Air Freight & Logistics sector continue expanding? Could Hong diversify its offerings? Factors like these will boost the valuation of Hong Kong. Market participants price Hong higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Hong Kong data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.302
Revenue Per Share
1.99
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0132
Return On Equity
(0.01)
The market value of Hong Kong Pharma is measured differently than its book value, which is the value of Hong that is recorded on the company's balance sheet. Investors also form their own opinion of Hong Kong's value that differs from its market value or its book value, called intrinsic value, which is Hong Kong's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Hong Kong's market value can be influenced by many factors that don't directly affect Hong Kong's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hong Kong's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hong Kong is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Hong Kong's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.